Literature DB >> 10704085

Prevention of antigen-induced bronchial hyperreactivity and airway inflammation in sensitized guinea-pigs by tacrolimus.

J R Lapa e Silva1, C Ruffié, J Lefort, M A Nahori, B B Vargaftig, M Pretolani.   

Abstract

We examined the effect of the immunosuppressive agent, tacrolimus (FK506), on antigen-induced bronchial hyperreactivity to acetylcholine and leukocyte infiltration into the airways of ovalbumin-challenged guinea-pigs. Subcutaneous injection of 0.5 mg/kg of FK506, 1 h before and 5 h after intra-nasal antigen challenge prevented bronchial hyperreactivity to aerosolized acetylcholine, eosinophilia in bronchoalveolar lavage (BAL) fluid and bronchial tissue and the invasion of the bronchial wall by CD4+ T-lymphocytes. FK506 also suppressed ovalbumin-induced increase in the number of leukocytes adhering to the pulmonary vascular endothelium and expressing alpha4-integrins. Inhibition by FK506 of antigen-induced bronchial hyperreactivity in sensitized guinea-pigs may thus relate to its ability to prevent the emergence of important inflammatory components of airway inflammation, such as eosinophil accumulation, as well as CD4+ T-lymphocyte infiltration into the bronchial tissue.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10704085      PMCID: PMC1781777          DOI: 10.1080/09629359990676

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  34 in total

Review 1.  GM-CSF, IL-3 and IL-5: cross-competition on human haemopoietic cells.

Authors:  A F Lopez; M J Elliott; J Woodcock; M A Vadas
Journal:  Immunol Today       Date:  1992-12

2.  Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma.

Authors:  M Azzawi; B Bradley; P K Jeffery; A J Frew; A J Wardlaw; G Knowles; B Assoufi; J V Collins; S Durham; A B Kay
Journal:  Am Rev Respir Dis       Date:  1990-12

3.  Characterization of the anti-inflammatory effect of FK-506 on human mast cells.

Authors:  A de Paulis; R Cirillo; A Ciccarelli; G de Crescenzo; A Oriente; G Marone
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

4.  Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.

Authors:  Q Hamid; M Azzawi; S Ying; R Moqbel; A J Wardlaw; C J Corrigan; B Bradley; S R Durham; J V Collins; P K Jeffery
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

5.  Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. Correlation with distinct alpha 4 epitopes.

Authors:  R Pulido; M J Elices; M R Campanero; L Osborn; S Schiffer; A García-Pardo; R Lobb; M E Hemler; F Sánchez-Madrid
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

6.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.

Authors:  D S Robinson; Q Hamid; S Ying; A Tsicopoulos; J Barkans; A M Bentley; C Corrigan; S R Durham; A B Kay
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

7.  Cyclosporin A and FK506 mediate differential effects on T cell activation in vivo.

Authors:  D K Bishop; W Li
Journal:  J Immunol       Date:  1992-02-15       Impact factor: 5.422

8.  Cyclosporine and FK506 inhibition of murine mast cell cytokine production.

Authors:  S M Hatfield; N W Roehm
Journal:  J Pharmacol Exp Ther       Date:  1992-02       Impact factor: 4.030

Review 9.  T cells and eosinophils in the pathogenesis of asthma.

Authors:  C J Corrigan; A B Kay
Journal:  Immunol Today       Date:  1992-12

10.  Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects.

Authors:  A B Kay; S Ying; V Varney; M Gaga; S R Durham; R Moqbel; A J Wardlaw; Q Hamid
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.